© 2020 MJH Life Sciences™ and Urology Times. All rights reserved.
Practice Management
Besides the expansion of telemedicine, how has COVID-19 affected your practice?
September 17, 2020
"We’re taking it in stride. We don’t overbook to the point where we’re overwhelmed, and we’re not exhausting ourselves," says one urologist.
Open Payments and urology: What do the latest data reveal?
September 07, 2020
"Three products alone used to treat advanced prostate cancer were associated with about half of all payments to urologists," writes Robert A. Dowling, MD.
Is carrying cyber insurance needed in a medical practice?
August 27, 2020
"We had a Russian-based attack. All of our data was encrypted. They said they’d give us back our data for $24,000 in bitcoins," says one urologist.
How to use data to measure adherence to clinical guidelines in prostate cancer
August 17, 2020
Against the backdrop of a new guideline for advanced prostate cancer, Robert A. Dowling, MD, describes how you might measure adherence to guidelines in your own practice.
What has been the telemedicine experience in urology during the COVID-19 pandemic?
July 09, 2020
3 urologists discuss their experience with telemedicine during the COVID-19 pandemic.
It’s time to prepare for upcoming E/M coding changes
June 29, 2020
The deletion of code 99201 is among the evaluation/management coding changes for 2021.
Pandemic exacts economic toll on urology practices
June 18, 2020
As practices reboot, urologists consider leaner staffs and operations.
Denosumab tops spending for common urology Part B drugs
June 16, 2020
Mitomycin sees the largest annual growth in spending per dose over the past 5 years, Robert A. Dowling, MD, reports.
How to code for a perineal prostate biopsy
June 15, 2020
Three codes are available for prostate biopsy, but only one is typically used for perineal biopsy, according to Jonathan Rubenstein, MD, and Mark Painter.
How to restart your practice when the COVID-19 red light turns green
June 11, 2020
"In the current environment of coronavirus disease 2019 (COVID-19), it has become obvious that it won’t be business as usual when the economy restarts and social distancing restrictions are relaxed," write Steven A. Kaplan, MD, and Alexis E. Te, MD.